Abstract
Human participants provide a variety of materials that are essential for research in regenerative medicine, including adult stem cells, embryos, sperm, ova, blood, and urine. Because regenerative medicine depends so heavily on the cooperation of human participants, researchers must take appropriate measures to protect their rights and welfare and secure their trust. This chapter focuses on some emerging issues in the procurement of materials in regenerative medicine research that merit special attention, including informed consent and confidentiality. Though these issues also arise in other types of biomedical research, regenerative medicine investigators face some unique challenges, due to the nature of their subject matter. Since the ethical questions and problems related to procurement of human biological materials are likely to change in response to advances in science and technology, it is important for regenerative medicine researchers to stay abreast of current policies and ethical guidance and to think critically about the dilemmas they face.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aalto-Setälä, K., Conklin, B. R., & Lo, B. (2009). Obtaining consent for future research with induced pluripotent cells: Opportunities and challenges. PLoS Biology, 7(2), e42.
Beskow, L. M., Dame, L., & Costello, E. J. (2008). Research ethics. Certificates of confidentiality and compelled disclosure of data. Science, 322, 1054–1055.
Brock, D. (2008). Philosophical justifications of informed consent in research. In E. Emanuel, C. Grady, R. Crouch, et al. (Eds.), The Oxford textbook of clinical research ethics. New York: Oxford University Press.
Capron, A. M. (2008). Legal and regulatory standards of informed consent in research. In E. Emanuel, C. Grady, R. Crouch, et al. (Eds.), The Oxford textbook of clinical research ethics. New York: Oxford University Press.
Cohen, C. B. (2007). Renewing the stuff of life: Stem cells, ethics, and public policy. New York: Oxford University Press.
Cohen, C. B. (2009). Ethical and policy issues surrounding the donation of cryopreserved and fresh embryos for human embryonic stem cell research. Stem Cell Reviews and Reports, 5, 116–122.
Department of Health and Human Services. (2009). Protection of human subjects, 45 CFR 46. Retrieved June 14, 2012, form http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm.
Dickenson, D. (2009). Good science and good ethics: Why we should discourage payment for eggs for stem cell research. Nature Reviews Genetics, 10, 743.
El Emam, K., Arbuckle, L., Koru, G., et al. (2011). The re-identification risk of Canadians from longitudinal demographics. BMC Medical Information and Decision Making, 11, 46.
Grady, C. (2005). Payment of clinical research subjects. Journal of Clinical Investigation, 115, 1681–1687.
Grady, C., Dickert, N., Jawetz, T., et al. (2005). An analysis of U.S. practices of paying research participants. Contemporary Clinical Trials, 26, 365–375.
Hodge, J., & Gostin, L. (2008). Confidentiality. In E. Emanuel, C. Grady, R. Crouch, et al. (Eds.), The Oxford textbook of clinical research ethics. New York: Oxford University Press.
Homer, N., Szelinger, S., Redman, M., et al. (2008). Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genetics, 4(8), e1000167.
International Society for Stem Cell Research. (2006). Guidelines of the conduct of human embryonic stem cell research. Retrieved June 14, 2012, from http://www.isscr.org/AM/Template.cfm?Section=GuidelinesforhESCResearch&Template=/CM/ContentDisplay.cfm&ContentID=2916.
Isasi, R., Knoppers, B. M., & Lomax, G. (2011). Sustained interaction: The new normal for stem cell repositories? Regenerative Medicine, 6, 783–792.
McGuire, A., & Gibbs, R. (2006). No longer de-identified. Science, 312, 370–371.
National Academy of Sciences. (2005). Guidelines for human embryonic stem cell research. Washington, DC: National Academies Press.
National Institutes of Health. (2009). Guidelines for human stem cell research. Retrieved May, 29, 2012, from http://stemcells.nih.gov/policy/2009guidelines.htm.
National Institutes of Health. (2010). Policy for sharing of data obtained in NIH supported or conducted genome-wide association studies (GWAS). Retrieved June 14, 2012, from http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088.html.
Petrini, C. (2010). “Broad” consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose. Social Science and Medicine, 70, 217–220.
Resnik, D. B. (2001). Regulating the market for human eggs. Bioethics, 15, 1–25.
Resnik, D. B. (2004). Owning the genome: A moral analysis of DNA patents. Albany, NY: State University of New York Press.
Resnik, D. B. (2009). Re-consenting human subjects: Ethical, legal and practical issues. Journal of Medical Ethics, 35, 656–657.
Resnik, D. B. (2010). Genomic research data: Open vs. restricted access. IRB, 32(1), 1–6.
Resnik, D. B. (2011). Disclosure of individualized research results: A precautionary approach. Accountability in Research, 18, 382–397.
Salvaterra, E., Lecchi, L., Giovanelli, S., et al. (2008). Banking together: A unified model of informed consent for biobanking. EMBO Reports, 9, 307–313.
Shamoo, A. S., & Resnik, D. B. (2009). Responsible conduct of research (2nd ed.). New York: Oxford University Press.
Skloot, R. (2010). The immortal life of Henrietta Lacks. New York: Crown.
Steinbock, B. (2004). Payment for egg donation and surrogacy. Mount Sinai Journal of Medicine, 71, 255–265.
Streiffer, R. (2008). Informed consent and federal funding for stem cell research. Hastings Center Report, 38(3), 40–47.
Weir, R., & Olick, R. (2004). The stored tissue issue. New York: Oxford University Press.
Wendler, D. (2006). One-time general consent for research on biological samples. British Medical Journal, 332, 544–547.
Wertheimer, A. (2010). Rethinking the ethics of clinical research: Widening the lens. New York: Oxford University Press.
Wolf, S. M., Lawrenz, F. P., Nelson, C. A., et al. (2008). Managing incidental findings in human subjects research: Analysis and recommendations. Journal of Law, Medicine & Ethics, 36, 219–248.
World Medical Association. (2008). Declaration of Helsinki. Retrieved June 14, 2012, from http://www.wma.net/en/30publications/10policies/b3/index.html
Acknowledgements
This article is the work product of an employee or group of employees of the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH); however, the statements, opinions, or conclusions contained therein do not necessarily represent the statements, opinions, or conclusions of NIEHS, NIH, or the United States government.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Resnik, D.B. (2014). Protecting Human Participants in the Procurement of Materials in Regenerative Medicine Research. In: Hogle, L. (eds) Regenerative Medicine Ethics. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9062-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9062-3_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9061-6
Online ISBN: 978-1-4614-9062-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)